Open Orphan (ORPH) |

Alan Green presents the investment case for Open Orphan #ORPH and British Honey Company #BHC on his weekly Stockbox Media Research talk

Open Orphan #ORPH – Statement re further media comment on UK Government and other partners for a UK Coronavirus challenge study

Further to our announcement of 24 September 2020 and further media comment the Company confirms that it remains in advanced negotiations with the UK Government and other partners for a Coronavirus challenge study in the UK. No contract has been signed and the Company will update the market in due course as appropriate. For further […]

Most people try to avoid Covid-19. But thousands are signing up to be deliberately exposed – CNN

By Mick Krever, Phil Black and Cristiana Moisescu, London (CNN) – As most of us obsess with avoiding Covid-19 at all costs, a rapidly growing group of people around the world say they are prepared to deliberately take on the virus. Tens of thousands of people have signed up to a campaign by a group called 1 Day Sooner to […]

Daily Telegraph – When will a Covid-19 vaccine be ready in the UK? Latest updates from around the world

ByAnnelies Gartner ; Lizzie Roberts and Christopher Hope, Volunteers could soon be deliberately infected with coronavirus in trials to speed up a vaccine and discover if people are protected if they have already had the disease. In a groundbreaking trial, scheduled to begin in January at the Royal Free Hospital in London, patients will be inoculated with a vaccine developed by Imperial College, […]

Alan Green on Trump/Biden, plus Open Orphan #ORPH, Erris Resources #ERIS & Tertiary Minerals #TYM on the UK Investor Mag podcast

Alan Green discusses the Trump/Biden effect on the markets, plus Open Orphan #ORPH, Erris Resources #ERIS and Tertiary Minerals #TYM with Jonathan Roy on the UK Investor Magazine podcast.

Open Orphan #ORPH – Interim Results for 6 months ended 30 June, will be operationally profitable in Q4

Open Orphan Plc, a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical studies is pleased to announce its interim results for the six months ended 30 June 2020. The interim results include the first six months of hVIVO group (“hVIVO”) following its […]

The Times – Trial to infect British volunteers with modified coronavirus at hVIVO Quarantine Centre

Scientists are planning to infect British volunteers with a weakened, computer-designed form of the coronavirus, which researchers believe could work as a vaccine. The early-stage trial will take place in a special 24-bed quarantine clinic in Whitechapel, east London. The US biotech company behind it, Codagenix, is in talks with UK regulators and expects to […]

Alan Green discusses Open Orphan #ORPH, Kingfisher #KGF & Castillo Copper #CCZ on Vox Markets podcast

Alan Green discusses Open Orphan #ORPH, Kingfisher #KGF & Castillo Copper #CCZ with Justin Waite on the Vox Markets podcast. Interview starts at 10 minutes 42 seconds.

Open Orphan #ORPH – New £4.3m Challenge Study Contract Win with Global Top 10 Vaccine Company

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce a new £4.3 million contract to conduct a human viral challenge study utilising one of our 8 traditional challenge study models for another […]

Open Orphan #ORPH – Statement re price movement and press speculation

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials notes the recent share price movement and press speculation regarding UK government-funded Coronavirus human challenge studies. The Company confirms that it is in advanced negotiation with […]